健康大视野·医学分册2023,Issue(2) :249-251.

阿奇霉素在治疗小儿支原体肺炎的临床研究进展

Clinical Research Progress of Azithromycin in Treating Mycoplasma Pneumonia in Children

张凤梅
健康大视野·医学分册2023,Issue(2) :249-251.

阿奇霉素在治疗小儿支原体肺炎的临床研究进展

Clinical Research Progress of Azithromycin in Treating Mycoplasma Pneumonia in Children

张凤梅1
扫码查看

作者信息

  • 1. 菏泽市中医医院,山东 菏泽 274035
  • 折叠

摘要

支原体肺炎是儿童常见的一种疾病,病程较长,临床症状复杂多变,容易导致机体多个器官损伤,病情发展严重甚至会引起死亡.目前临床上常用的药物是大环内酯类药物,临床研究表明,阿奇霉素作为代表具有显著的疗效和作用,得到广泛的应用.为了不断提高阿奇霉素应用效果,临床研究中逐渐联合其它药物使用,在小儿支原体肺炎中取得了较为满意的疗效.本文探讨阿奇霉素在治疗小儿支原体肺炎的临床研究进展,根据小儿支原体肺炎的发病机制,基于阿奇霉素治疗小儿肺炎支原体的依据,分析阿奇霉素的相关治疗方法,期望为临床小儿支原体肺炎的治疗提供一定的

Abstract

Mycoplasma pneumonia is a common disease in children. It has a long course of disease, complex and changeable clinical symptoms, and is easy to lead to multiple organ damage, serious disease development and even death. At present, the commonly used drugs in clinic are macrolides. Clinical studies show that azithromycin, as a representative, has significant curative effects and effects and is widely used. In order to continuously improve the application effect of azithromycin, it is gradually used in combination with other drugs in clinical research, and has achieved satisfactory results in children with mycoplasma pneumonia. This article discusses the clinical research progress of azithromycin in the treatment of mycoplasma pneumonia in children. According to the pathogenesis of mycoplasma pneumonia in children, based on the basis of azithromycin in the treatment of mycoplasma pneumonia in children, this article analyzes the relevant treatment methods of azithromycin, hoping to provide some reference for the treatment of mycoplasma pneumonia in children.

关键词

阿奇霉素/抗生素/小儿支原体肺炎/研究进展

Key words

azithromycin/antibiotic/Mycoplasma pneumonia in children/Research progress

引用本文复制引用

出版年

2023
健康大视野·医学分册
中国保健协会

健康大视野·医学分册

ISSN:1005-0019
段落导航相关论文